# Yutaka Nishiwaki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yutaka-nishiwaki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,185 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 70 |
| i10-index | 182 |
| Last Known Institution | National Cancer Centre Japan |
| OpenAlex ID | https://openalex.org/A5109212857 |
| Works | 362 |

## Researcher papers

- [Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma](https://scholariq.org/papers/gefitinib-or-carboplatin-paclitaxel-in-pulmonary-adenocarcinoma/)
- [Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan](https://scholariq.org/papers/randomized-phase-iii-study-of-cisplatin-plus-irinotecan-versus-carboplatin-plus/)
- [Interstitial Lung Disease in Japanese Patients with Lung Cancer](https://scholariq.org/papers/interstitial-lung-disease-in-japanese-patients-with-lung-cancer/)
- [Predominant infiltration of macrophages and CD8<sup>+</sup> T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer](https://scholariq.org/papers/predominant-infiltration-of-macrophages-and-cd8-sup-sup-t-cells-in-cancer-nests/)
- [Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer](https://scholariq.org/papers/phase-iii-study-v-15-32-of-gefitinib-versus-docetaxel-in-previously-treated/)
- [Breast Cancer Resistance Protein Impacts Clinical Outcome in Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer](https://scholariq.org/papers/breast-cancer-resistance-protein-impacts-clinical-outcome-in-platinum-based/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Researcher university

- [National Cancer Centre Japan](https://scholariq.org/institutions/national-cancer-centre-japan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.